one hundred eight-six patients with active rheumatoid arthritis were evaluated in a double-blind , randomized study that compared treatment with sulfasalazine ( ssz ) ( 2 mg/day ) , gold sodium thiomalate ( gst ) ( 50 mg/week ) , and placebo ( pbo ) .
C0003873
rheumatoid arthritis
C0018034
gold sodium thiomalate